Renagel
Product Images NDC 68151-4295

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Renagel (NDC 68151-4295). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl681514295)

Renagel is a medication that contains sevelamer HCL in tablet form with each tablet containing 400mg. It is manufactured by Genzyme with a lot number of B6588BG1 and an expiration date of 112/47. The medication is only available for prescription and has an NDC number of 58468-0028-61. The text also includes an illegible code number at the bottom.*

FDA Label Image

Figure 1 (Renagel 01)

FDA Label Image

Figure 2 (Renagel 02)

This appears to be a graph or chart related to a medical study/trial involving a medication called Sevelamer Hydrochloride and its effects on reducing serum phosphorus levels in patients. The graph shows a reduction from baseline levels over time and suggests that the medication is effective in improving patients' conditions.*

FDA Label Image

Figure 3 (Renagel 03)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.